Replacing the diseased aortic valve and the proximal aorta in the elderly patient.
Subcoronary implantation of the Medtronic stentless bioprosthesis and an extension using a vascular tube prosthesis provide a safer alternative to the more invasive conventional composite graft replacement or a full root replacement using a homograft or a stentless valve. The advantage lies in eliminating the need for coronary mobilisation and anastomosis which actually lead to the increased risk in those procedures.
John
Alexander
A
Department of Cardiac Surgery, Schuechtermann Klinik, 49214 Bad Rothenfelde, Germany. ajohn@schuechtermann-klinik.de
Al-Hariri
Basel
B
Ackemann
Juergen
J
Warnecke
Henning
H
D000368:Aged; D000369:Aged, 80 and over; D001018:Aortic Diseases / Q000150:complications / Q000601:surgery; D001021:Aortic Valve / Q000601:surgery*; D001705:Bioprosthesis; D006349:Heart Valve Diseases / Q000150:complications / Q000601:surgery*; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008875:Middle Aged; D016896:Treatment Outcome